Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cohen

Showing results (1061-1070 of 1,179) with videos related to

Pageof 118
Sort By:
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 8, 2016
Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerationsGeoffrey M Reed, Jack Drescher, Richard B Krueger, et al.
Epilepsia|June 23, 2023
Focal to bilateral tonic-clonic seizures predict pharmacoresistance in focal cortical dysplasia-related epilepsyPhat Chang, Hua Xie, Venkata Sita Priyanka Illapani, et al.
Journal of Personality Assessment|October 20, 2009
Cross-national replication of the gender identity interview for childrenMadeleine S C Wallien, Lena C Quilty, Thomas D Steensma, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 9, 2022
Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American PerspectiveRodrigo Abensur Athanazio, José Manuel Ceresetto, Luis Javier Marfil Rivera, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2017
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trialMegan K Yee, Tarek Nafee, Yazan Daaboul, et al.
Circulation|November 25, 2016
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)C Michael Gibson, Gerald Chi, Rim Halaby, et al.
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology SettingTanya G K Bentley, Joshua T Cohen, Elena B Elkin, et al.
Archives of Sexual Behavior|October 18, 2015
Body Satisfaction and Physical Appearance in Gender DysphoriaTim C van de Grift, Peggy T Cohen-Kettenis, Thomas D Steensma, et al.
Psychosomatic Medicine|June 25, 2019
Mental Health of a Large Group of Adults With Disorders of Sex Development in Six European CountriesAnnelou L C de Vries, Robert Roehle, Louise Marshall, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 16, 2023
Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US ProgramKimberly Snow Caroti, Alok A Khorana, Cecilia Becattini, et al.
Pageof 118

Showing results (1061-1070 of 1,179) with videos related to

Sort By:
Pageof 118
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 8, 2016
Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerationsGeoffrey M Reed, Jack Drescher, Richard B Krueger, et al.
Epilepsia|June 23, 2023
Focal to bilateral tonic-clonic seizures predict pharmacoresistance in focal cortical dysplasia-related epilepsyPhat Chang, Hua Xie, Venkata Sita Priyanka Illapani, et al.
Journal of Personality Assessment|October 20, 2009
Cross-national replication of the gender identity interview for childrenMadeleine S C Wallien, Lena C Quilty, Thomas D Steensma, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 9, 2022
Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American PerspectiveRodrigo Abensur Athanazio, José Manuel Ceresetto, Luis Javier Marfil Rivera, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2017
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trialMegan K Yee, Tarek Nafee, Yazan Daaboul, et al.
Circulation|November 25, 2016
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)C Michael Gibson, Gerald Chi, Rim Halaby, et al.
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology SettingTanya G K Bentley, Joshua T Cohen, Elena B Elkin, et al.
Archives of Sexual Behavior|October 18, 2015
Body Satisfaction and Physical Appearance in Gender DysphoriaTim C van de Grift, Peggy T Cohen-Kettenis, Thomas D Steensma, et al.
Psychosomatic Medicine|June 25, 2019
Mental Health of a Large Group of Adults With Disorders of Sex Development in Six European CountriesAnnelou L C de Vries, Robert Roehle, Louise Marshall, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 16, 2023
Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US ProgramKimberly Snow Caroti, Alok A Khorana, Cecilia Becattini, et al.
Pageof 118